Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
30 April
PharmaCyte Biotech, Inc. has filed 469 SEC EDGAR filings since 20 Aug 2001

SEC filing history

Showing 26-50 of 389 matching filings.

Per page
25
Current page
2
4 File 001-36268

4 filing

Filing date
18 Nov 2025
Reporting date
04 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date
18 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91495

SCHEDULE 13G/A filing

Filing date
07 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40699

DEFINITIVE PROXY STATEMENT

Filing date
06 Oct 2025
Reporting date
30 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-290311

EFFECT filing

Filing date
26 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40699

PRELIMINARY PROXY STATEMENT

Filing date
24 Sep 2025
Reporting date
30 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-290311

UPLOAD filing

Filing date
23 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40699

FORM 10-Q FOR JUL 2025

Filing date
15 Sep 2025
Reporting date
31 Jul 2025
Next action
Verify source filing
D File 021-556587

D filing

Filing date
04 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40699

CURRENT REPORT

Filing date
18 Aug 2025
Reporting date
17 Aug 2025
Next action
Verify source filing
10-K File 001-40699

FORM 10-K FOR APR 2025

Filing date
11 Aug 2025
Reporting date
30 Apr 2025
Next action
Verify source filing
NT 10-K File 001-40699

EXTENSION

Filing date
29 Jul 2025
Reporting date
30 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40699

FORM 10-Q FOR JAN 2025

Filing date
17 Mar 2025
Reporting date
31 Jan 2025
Next action
Verify source filing
ARS File 001-40699

FORM ARS

Filing date
10 Mar 2025
Reporting date
30 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-40699

FORM DEFA 14A

Filing date
10 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40699

DEFINITIVE PROXY STATEMENT

Filing date
10 Mar 2025
Reporting date
24 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91495

SCHEDULE 13G/A filing

Filing date
13 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .